Literature DB >> 23781963

Evaluation of dermal myelinated nerve fibers in diabetes mellitus.

Amanda C Peltier1, M Iliza Myers, Kay J Artibee, Audra D Hamilton, Qing Yan, Jiasong Guo, Yaping Shi, Lily Wang, Jun Li.   

Abstract

Skin biopsies have primarily been used to study the non-myelinated nerve fibers of the epidermis in a variety of neuropathies. In this study, we have expanded the skin biopsy technique to glabrous, non-hairy skin to evaluate myelinated nerve fibers in the most highly prevalent peripheral nerve disease, diabetic polyneuropathy (DPN). Twenty patients with DPN (Type I, n = 9; Type II, n = 11) and 16 age-matched healthy controls (age 29-73) underwent skin biopsy of the index finger, nerve conduction studies (NCS), and composite neuropathy scoring. In patients with DPN, we found a statistically significant reduction of both mechanoreceptive Meissner corpuscles (MCs) and their afferent myelinated nerve fibers (p = 0.01). This myelinated nerve fiber loss was correlated with the decreased amplitudes of sensory/motor responses in NCS. This study supports the utilization of skin biopsy to quantitatively evaluate axonal loss of myelinated nerve fibers in patients with DPN.
© 2013 Peripheral Nerve Society.

Entities:  

Mesh:

Year:  2013        PMID: 23781963      PMCID: PMC3693761          DOI: 10.1111/jns5.12027

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  27 in total

1.  Effect of an R69C mutation in the myelin protein zero gene on myelination and ion channel subtypes.

Authors:  Yunhong Bai; Emilia Ianokova; Qin Pu; Khaled Ghandour; Rock Levinson; Jean-Jacques Martin; Chantal Ceuterick-de Groote; Radim Mazanec; Pavel Seeman; Michael E Shy; Jun Li
Journal:  Arch Neurol       Date:  2006-12

2.  Sural nerve pathology in diabetic patients with minimal but progressive neuropathy.

Authors:  R A Malik; S Tesfaye; P G Newrick; D Walker; S M Rajbhandari; I Siddique; A K Sharma; A J M Boulton; R H M King; P K Thomas; J D Ward
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

3.  Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.

Authors:  A A Sima; V Nathaniel; V Bril; T A McEwen; D A Greene
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

4.  Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside.

Authors:  Jun Li; Yunhong Bai; Khaled Ghandour; Pu Qin; Marina Grandis; Anna Trostinskaia; Emilia Ianakova; Xingyao Wu; Angelo Schenone; Jean-Michel Vallat; William J Kupsky; James Hatfield; Michael E Shy
Journal:  Brain       Date:  2005-03-17       Impact factor: 13.501

5.  Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale.

Authors:  Anna Maria Carlsson
Journal:  Pain       Date:  1983-05       Impact factor: 6.961

6.  Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration.

Authors:  Jun Li; Yunhong Bai; Emilia Ianakova; Marina Grandis; Fred Uchwat; Anna Trostinskaia; Karen M Krajewski; James Garbern; William J Kupsky; Michael E Shy
Journal:  J Comp Neurol       Date:  2006-09-10       Impact factor: 3.215

7.  Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy.

Authors:  M W Kalichman; H C Powell; A P Mizisin
Journal:  Acta Neuropathol       Date:  1998-01       Impact factor: 17.088

8.  Axonal transection in the lesions of multiple sclerosis.

Authors:  B D Trapp; J Peterson; R M Ransohoff; R Rudick; S Mörk; L Bö
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

9.  Acute demyelination disrupts the molecular organization of peripheral nervous system nodes.

Authors:  Edgardo J Arroyo; Erich E Sirkowski; Rohan Chitale; Steven S Scherer
Journal:  J Comp Neurol       Date:  2004-11-22       Impact factor: 3.215

10.  A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy.

Authors:  E L Feldman; M J Stevens; P K Thomas; M B Brown; N Canal; D A Greene
Journal:  Diabetes Care       Date:  1994-11       Impact factor: 19.112

View more
  5 in total

1.  In-vivo reflectance confocal microscopy of Meissner's corpuscles in diabetic distal symmetric polyneuropathy.

Authors:  Peter D Creigh; Michael P McDermott; Janet E Sowden; Michele Ferguson; David N Herrmann
Journal:  J Neurol Sci       Date:  2017-05-12       Impact factor: 3.181

2.  The relationship of nerve fibre pathology to sensory function in entrapment neuropathy.

Authors:  Annina B Schmid; Jeremy D P Bland; Manzoor A Bhat; David L H Bennett
Journal:  Brain       Date:  2014-10-27       Impact factor: 13.501

3.  Development of grading scales of pedal sensory loss using Mokken scale analysis on the Rotterdam Diabetic Foot Study Test Battery data.

Authors:  Willem D Rinkel; M Hosein Aziz; Johan W Van Neck; Manuel Castro Cabezas; L Andries van der Ark; J Henk Coert
Journal:  Muscle Nerve       Date:  2019-07-24       Impact factor: 3.217

4.  Vibrotactile sense 5 years after carpal tunnel release in people with diabetes: A prospective study with matched controls.

Authors:  Niels O B Thomsen; Lars B Dahlin
Journal:  Diabet Med       Date:  2020-11-26       Impact factor: 4.359

Review 5.  Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review.

Authors:  Eleonora Galosi; Xiaoli Hu; Nivatha Michael; Jens Randel Nyengaard; Andrea Truini; Páll Karlsson
Journal:  Acta Diabetol       Date:  2021-07-02       Impact factor: 4.280

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.